Pharmacogenomics-Based Detection of Variants Involved in Pain, Anti-inflammatory and Immunomodulating Agents Pathways by Whole Exome Sequencing and Deep in Silico Investigations Revealed Novel Chemical Carcinogenesis and Cancer Risks
Background: Next-Generation Sequencing (NGS) methods specifically Whole-Exome Sequencing (WES) have demonstrated promising findings with a high accuracy of 91%-99% in Pharmacogenomics (PGx). A PGx-based panel can be utilized to minimize adverse drug reactions (ADRs) and maximize the treatment effica...
Saved in:
| Main Authors: | Alireza Sharafshah, Majid Motovali-Bashi, Parvaneh Keshavarz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shiraz University of Medical Sciences
2025-02-01
|
| Series: | Iranian Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://ijms.sums.ac.ir/article_50438_08d496e83abcf5314728148bca1bcbab.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
by: Simran Maggo, et al.
Published: (2025-05-01) -
Correction: Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
by: Simran Maggo, et al.
Published: (2025-07-01) -
Identification of a rare variant in TNNT3 responsible for familial dilated cardiomyopathy through whole-exome sequencing and in silico analysis
by: Motahareh Jadidi, et al.
Published: (2025-05-01) -
PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015-09-01) -
Benchmarking of variant calling software for whole-exome sequencing using gold standard datasets
by: Matthew Wong, et al.
Published: (2025-04-01)